Skip to content

Mechanisms of brain microstructural alterations and functional network abnormalities in relation to intestinal inflammatory activity and prognosis in patients with inflammatory bowel disease

Mechanisms of brain microstructural alterations and functional network abnormalities in relation to intestinal inflammatory activity and prognosis in patients with inflammatory bowel disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073847
Enrollment
Unknown
Registered
2023-07-24
Start date
2023-07-25
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

Group A (IBD active group):No
Group B (IBD remission group):No
Group C (Healthy group):No

Sponsors

Changzhou No.2 People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1: Meets diagnostic criteria for inflammatory bowel disease. 2: Age between 18 and 65 years. 3: No history of abdominal surgery. 4: No contraindications to MRI examination. 5: Inclusion criteria for normal controls: a) Age between 18 and 65 years. b)Lower secondary education or above. c) All right-handed. MoCA score =26.

Exclusion criteria

Exclusion criteria: 1: Severe neurological pathologies such as tumours, stroke and traumatic brain injury. 2: Acute cardiovascular disease such as acute arterial embolism and acute heart failure. History of neurodegenerative diseases such as Parkinson's disease or Alzheimer's disease. 3: Those with claustrophobia who are unable to have an MR scan. A history of any drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
cranial MRI;Colonoscopy;

Secondary

MeasureTime frame
Psychological scales;Inflammatory factor levels;Plasma concentration;

Countries

China

Contacts

Public ContactLiu Wenjia

Changzhou No.2 People's Hospital

13813016290@126.com+86 138 1301 6290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026